{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:45:14Z","timestamp":1792687514125,"version":"4.5.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY027308"],"award-info":[{"award-number":["EY027308"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL133761"],"award-info":[{"award-number":["HL133761"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.survophthal.2021.08.010","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:36:51Z","timestamp":1630708611000},"page":"858-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-350X","authenticated-orcid":false,"given":"Vardaan","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-3671","authenticated-orcid":false,"given":"Christine L.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Roztocil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithra O.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Feldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7197-5057","authenticated-orcid":false,"given":"Collynn F.","family":"Woeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.survophthal.2021.08.010_bib0001","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1507\/endocrj.EJ18-0074","article-title":"Enduring remission of active and sight-threatening Graves' orbitopathy with rituximab: report of two cases","volume":"65","author":"Adamidou","year":"2018","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2265.2008.03343.x","article-title":"The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO)","volume":"70","author":"Alevizaki","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0003","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ophtha.2021.03.006","article-title":"A perspective on the current role of teprotumumab in treatment of thyroid eye disease","volume":"128","author":"Allen","year":"2021","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm3611","article-title":"Diversifying microRNA sequence and function","volume":"14","author":"Ameres","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejmech.2019.05.031","article-title":"Salinomycin and its derivatives - A new class of multiple-targeted \"magic bullets\"","volume":"176","author":"Antoszczak","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0006","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/IOP.0000000000000211","article-title":"Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease","volume":"30","author":"Ayabe","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0008","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/249125","article-title":"Ophthalmopathy: VISA versus EUGOGO classification, assessment, and management","volume":"2015","author":"Barrio-Barrio","year":"2015","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves' Orbitopathy Guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0011","doi-asserted-by":"crossref","first-page":"725","DOI":"10.20452\/pamw.3592","article-title":"Cigarette smoking: number one enemy for Graves ophthalmopathy","volume":"126","author":"Bartalena","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves' orbitopathy","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0013","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0014","first-page":"3248","article-title":"Blockade of IGF\/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma","volume":"10","author":"Cao","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/925309","article-title":"Cross-talk between PPARs and the partners of RXR: A molecular perspective","volume":"2009","author":"Chan","year":"2009","journal-title":"PPAR Res"},{"issue":"17","key":"10.1016\/j.survophthal.2021.08.010_bib0016","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1074\/jbc.274.17.12115","article-title":"Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation","volume":"274","author":"Chan","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0017","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1002\/jcb.27916","article-title":"The expression of interleukin-15 and interleukin-17 in tears and orbital tissues of Graves ophthalmopathy patients","volume":"120","author":"Chen","year":"2019","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0018","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1167\/iovs.15-18018","article-title":"Celecoxib and pioglitazone as potential therapeutics for regulating TGF-beta-Induced hyaluronan in dysthyroid myopathy","volume":"57","author":"Cheng","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0019","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1167\/iovs.15-18018","article-title":"Celecoxib and pioglitazone as potential therapeutics for regulating TGF-\u03b2-induced hyaluronan in dysthyroid myopathy","volume":"57","author":"Cheng","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"10.1016\/j.survophthal.2021.08.010_bib0020","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1167\/iovs.18-25134","article-title":"The effect of prostaglandin analogue bimatoprost on thyroid-associated orbitopathy","volume":"59","author":"Choi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.05.001","article-title":"Pirfenidone attenuates IL-1\u03b2-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-\u03baB activity","volume":"113","author":"Choi","year":"2013","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0022","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0023","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1167\/iovs.13-13759","article-title":"Pirfenidone attenuates the IL-1beta-induced hyaluronic acid increase in orbital fibroblasts from patients with thyroid-associated ophthalmopathy","volume":"55","author":"Chung","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0024","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/eji.200425778","article-title":"In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway","volume":"35","author":"Comalada","year":"2005","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0025","first-page":"365","article-title":"Selenium supplementation in thyroid associated ophthalmopathy: an update","volume":"7","author":"Dharmasena","year":"2014","journal-title":"Int J Ophthalmol"},{"issue":"4S Suppl 1","key":"10.1016\/j.survophthal.2021.08.010_bib0026","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","article-title":"Thyroid stimulating hormone receptor antibodies in thyroid eye disease-methodology and clinical applications","volume":"34","author":"Diana","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/IIO.0000000000000355","article-title":"Thyroid eye disease: Pathogenic risk factors","volume":"61","author":"Do","year":"2021","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2006.02542.x","article-title":"Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes","volume":"65","author":"Dorkhan","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0029","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fphar.2017.00877","article-title":"Curcumin suppresses the colon cancer proliferation by inhibiting Wnt\/\u03b2-catenin pathways via miR-130a","volume":"8","author":"Dou","year":"2017","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0031","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1089\/thy.2013.0194","article-title":"Effects of prostaglandin F(2\u03b1) on adipocyte biology relevant to graves' orbitopathy","volume":"23","author":"Draman","year":"2013","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0032","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/thy.2018.0506","article-title":"Prostaglandin F2-alpha eye drops (bimatoprost) in Graves' orbitopathy: A randomized controlled double-masked crossover trial (BIMA trial)","volume":"29","author":"Draman","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0033","first-page":"1","article-title":"Low-dose rituximab for active moderate-to-severe Graves' orbitopathy resistant to conventional treatment","author":"Du Pasquier-Fediaevsky","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0034","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0029-1220935","article-title":"Current insights into the pathogenesis of Graves' orbitopathy","volume":"41","author":"Eckstein","year":"2009","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcjo.2018.09.003","article-title":"Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease","volume":"54","author":"Eiger-Moscovich","year":"2019","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173238","article-title":"Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib","volume":"882","author":"Emori","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.08.010_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113603","article-title":"Old receptor, new tricks-the ever-expanding universe of aryl hydrocarbon receptor functions. report from the 4th AHR meeting, 29-31 August 2018 in Paris, France","volume":"19","author":"Esser","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.survophthal.2021.08.010_bib0038","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jclinpath-2012-200719","article-title":"Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathy","volume":"65","author":"Ezra","year":"2012","journal-title":"J Clin Pathol"},{"issue":"14","key":"10.1016\/j.survophthal.2021.08.010_bib0039","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1167\/iovs.16-20199","article-title":"IL-17A promotes RANTES expression, but not IL-16, in orbital fibroblasts via CD40-CD40L combination in thyroid-associated ophthalmopathy","volume":"57","author":"Fang","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0040","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2353\/ajpath.2006.060434","article-title":"Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes","volume":"169","author":"Feldon","year":"2006","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0041","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/en.2016-1382","article-title":"Intersection of chemokine and TSH receptor pathways in human fibrocytes: Emergence of CXCL-12\/CXCR4 cross talk potentially relevant to thyroid-associated ophthalmopathy","volume":"157","author":"Fernando","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2010.02.005","article-title":"The role of microRNA in rheumatoid arthritis and other autoimmune diseases","volume":"136","author":"Furer","year":"2010","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0043","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jid.2018.11.007","article-title":"A microRNA-29 mimic (Remlarsen) represses extracellular matrix expression and fibroplasia in the skin","volume":"139","author":"Gallant-Behm","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0044","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.taap.2016.03.005","article-title":"TCDD promoted EMT of hFPECs via AhR, which involved the activation of EGFR\/ERK signaling","volume":"298","author":"Gao","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4602854","article-title":"Aryl hydrocarbon receptor and stem cells","volume":"2017","author":"Gasiewicz","year":"2017","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0046","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-015-0614-x","article-title":"Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis","volume":"13","author":"Ghebremariam","year":"2015","journal-title":"J Transl Med"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0047","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1210\/jc.2016-1279","article-title":"Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking","volume":"101","author":"Gortz","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0048","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/en.2016-1304","article-title":"Pathogenic phenotype of adipogenesis and hyaluronan in orbital fibroblasts from female Graves' orbitopathy mouse model","volume":"157","author":"Gortz","year":"2016","journal-title":"Endocrinology."},{"issue":"21","key":"10.1016\/j.survophthal.2021.08.010_bib0049","doi-asserted-by":"crossref","first-page":"15794","DOI":"10.1074\/jbc.M109.074534","article-title":"Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease","volume":"285","author":"Guo","year":"2010","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.survophthal.2021.08.010_bib0050","doi-asserted-by":"crossref","first-page":"18856","DOI":"10.1074\/jbc.M110.179317","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0051","article-title":"Tocilizumab for thyroid eye disease","volume":"11","author":"Hamed Azzam","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0052","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.62.1.29","article-title":"MicroRNA-130a is elevated in thyroid eye disease and increases lipid accumulation in fibroblasts through the suppression of AMPK","volume":"62","author":"Hammond","year":"2021","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2021.08.010_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222779","article-title":"Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor","volume":"14","author":"Hammond","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0054","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1089\/thy.2017.0338","article-title":"Biguanides metformin and phenformin generate therapeutic effects via AMP-activated protein kinase\/extracellular-regulated kinase pathways in an in vitro model of Graves' orbitopathy","volume":"28","author":"Han","year":"2018","journal-title":"Thyroid."},{"issue":"9","key":"10.1016\/j.survophthal.2021.08.010_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222596","article-title":"The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology","volume":"14","author":"Heffer","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243626","article-title":"Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model","volume":"15","author":"Heffer","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0057","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/IOP.0000000000001437","article-title":"Serum vitamin D deficiency is an independent risk factor for thyroid eye disease","volume":"36","author":"Heisel","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0058","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/en.2018-00272","article-title":"HIF2A-LOX pathway promotes fibrotic tissue remodeling in thyroid-associated orbitopathy","volume":"160","author":"Hikage","year":"2019","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0059","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1158\/0008-5472.CAN-07-6168","article-title":"Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells","volume":"68","author":"Hollingshead","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BOR.0b013e32835b1352","article-title":"Myofibroblasts","volume":"25","author":"Hu","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0061","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1124\/mol.106.032748","article-title":"Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro","volume":"71","author":"Hu","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0062","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-011-1863-x","article-title":"Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy","volume":"250","author":"Huang","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0063","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0161-6420(91)32099-2","article-title":"Graves exophthalmos unrelated to extraocular muscle enlargement. Superior rectus muscle inflammation may induce venous obstruction","volume":"98","author":"Hudson","year":"1991","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0064","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1167\/iovs.08-2328","article-title":"Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1","volume":"50","author":"Hwang","year":"2009","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0065","series-title":"CADTH rapid response reports. Prostaglandin analogues for ophthalmic use: A review of comparative clinical effectiveness, cost-effectiveness, and guidelines","author":"Islam","year":"2020"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221077","article-title":"MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy","volume":"14","author":"Jang","year":"2019","journal-title":"PloS one"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0067","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1167\/iovs.16-19213","article-title":"Role of miR-146a in the regulation of inflammation in an in vitro model of Graves' orbitopathy","volume":"57","author":"Jang","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0068","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/bjophthalmol-2017-310723","article-title":"Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy","volume":"102","author":"Jang","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0069","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MED.0000000000000493","article-title":"Immunotherapies for thyroid eye disease","volume":"26","author":"Kahaly","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010212","article-title":"Curcumin metabolite tetrahydrocurcumin in the treatment of eye diseases","volume":"22","author":"Kao","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2021.08.010_bib0071","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","article-title":"Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications","volume":"54","author":"Kedika","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0072","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/cen.12392","article-title":"Serum selenium status in Graves' disease with and without orbitopathy: a case-control study","volume":"80","author":"Khong","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0073","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bjophthalmol-2020-316051","article-title":"Medical treatment in thyroid eye disease in 2020","volume":"105","author":"Khong","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0074","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","article-title":"Pathogenesis of thyroid eye disease: review and update on molecular mechanisms","volume":"100","author":"Khong","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.08.010_bib0075","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1167\/iovs.15-16870","article-title":"Therapeutic effect of resveratrol on oxidative stress in Graves' orbitopathy orbital fibroblasts","volume":"56","author":"Kim","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0076","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1167\/iovs.09-4257","article-title":"Antifibrotic effect of Pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels","volume":"51","author":"Kim","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0077","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00417-012-2092-7","article-title":"Increased serum interleukin-17 in Graves' ophthalmopathy","volume":"250","author":"Kim","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0078","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1507\/endocrj.EJ19-0521","article-title":"Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy","volume":"67","author":"Ko","year":"2020","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0079","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11154-018-9478-8","article-title":"Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?","volume":"19","author":"Koch","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrendo.2013.169","article-title":"Paediatrics: Circulating microRNAs-predictors of obesity?","volume":"9","author":"Koch","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0081","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","article-title":"Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes","volume":"32","author":"Koumas","year":"2002","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0082","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/en.2019-00055","article-title":"Arrestin-beta-1 physically scaffolds TSH and IGF1 receptors to enable crosstalk","volume":"160","author":"Krieger","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0083","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coemr.2018.01.007","article-title":"Thyroid stimulating hormone (TSH)\/insulin-like growth factor 1 (IGF1) receptor cross-talk in human cells","volume":"2","author":"Krieger","year":"2018","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"18","key":"10.1016\/j.survophthal.2021.08.010_bib0084","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186561","article-title":"Is there evidence for IGF1R-stimulating Abs in Graves' orbitopathy pathogenesis?","volume":"21","author":"Krieger","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0085","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/en.2017-00528","article-title":"TSH\/IGF-1 receptor cross-talk rapidly activates extracellular signal-regulated kinases in multiple cell types","volume":"158","author":"Krieger","year":"2017","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0086","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ceo.12163","article-title":"Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost","volume":"42","author":"Kucukevcilioglu","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0087","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/thy.2015.0254","article-title":"Forkhead transcription factor FOXO1 is regulated by both a stimulatory thyrotropin receptor antibody and insulin-like growth factor-1 in orbital fibroblasts from patients with Graves' ophthalmopathy","volume":"25","author":"Kumar","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0088","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2009.0278","article-title":"A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts","volume":"20","author":"Kumar","year":"2010","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0089","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/ICU.0b013e3283131557","article-title":"The eye and thyroid disease","volume":"19","author":"Kuriyan","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/thy.2007.0325","article-title":"Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib","volume":"18","author":"Kuriyan","year":"2008","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0091","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1167\/iovs.13-12741","article-title":"Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype","volume":"54","author":"Kuriyan","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2021.08.010_bib0092","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000509615","article-title":"Oxidative stress in Graves\u2019 disease and Graves orbitopathy","volume":"9","author":"Lanzolla","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0093","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fendo.2019.00933","article-title":"Cholesterol serum levels and use of statins in Graves' orbitopathy: A new starting point for the therapy","volume":"10","author":"Lanzolla","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0094","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1167\/iovs.61.8.51","article-title":"Glycogen synthase kinase-3beta mediates proinflammatory cytokine secretion and adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy","volume":"61","author":"Lee","year":"2020","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.survophthal.2021.08.010_bib0095","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1167\/iovs.19-27376","article-title":"Therapeutic effect of curcumin, a plant polyphenol extracted from curcuma longae, in fibroblasts from patients with Graves' orbitopathy","volume":"60","author":"Lee","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0096","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2415-7-8","article-title":"Thiazolidinedione induced thyroid associated orbitopathy","volume":"7","author":"Lee","year":"2007","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0097","doi-asserted-by":"crossref","first-page":"C672","DOI":"10.1152\/ajpcell.00451.2009","article-title":"Novel anti-adipogenic activity produced by human fibroblasts","volume":"299","author":"Lehmann","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0098","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archopht.123.1.119","article-title":"Rosiglitazone-induced proptosis","volume":"123","author":"Levin","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0099","doi-asserted-by":"crossref","first-page":"639","DOI":"10.12659\/MSM.890686","article-title":"Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy","volume":"20","author":"Li","year":"2014","journal-title":"Med Sci Monit"},{"issue":"7","key":"10.1016\/j.survophthal.2021.08.010_bib0100","first-page":"521","article-title":"Quercetin decreases proliferation of orbital fibroblasts and their release of hyaluronic acid","volume":"34","author":"Lisi","year":"2011","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0101","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2011.09.131","article-title":"TNF\u03b1-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors","volume":"414","author":"Liu","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0102","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1038\/s41388-021-01907-1","article-title":"Targeting the HIF-1alpha-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor","volume":"40","author":"Liu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","article-title":"TGF-beta1 - A truly transforming growth factor in fibrosis and immunity","volume":"101","author":"Lodyga","year":"2020","journal-title":"Semin Cell Dev Biol"},{"issue":"23","key":"10.1016\/j.survophthal.2021.08.010_bib0104","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139445","article-title":"Smooth muscle-derived progenitor cell myofibroblast differentiation through KLF4 downregulation promotes arterial remodeling and fibrosis","volume":"5","author":"Lu","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling Cross Talk between TGF-\u03b2\/Smad and Other Signaling Pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0106","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00011-010-0176-6","article-title":"Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress","volume":"59","author":"Lv","year":"2010","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0107","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bbrc.2018.02.037","article-title":"Modulation of hyaluronan polymer size regulates proliferation of perimysial fibroblasts in thyroid eye disease","volume":"496","author":"Ma","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0108","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1167\/iovs.18-26268","article-title":"PH20 inhibits TGFbeta1-induced differentiation of perimysial orbital fibroblasts via hyaluronan-CD44 Pathway in thyroid-associated ophthalmopathy","volume":"60","author":"Ma","year":"2019","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.carbpol.2017.08.082","article-title":"Application, mode of action, and in vivo activity of chitosan and its micro- and nanoparticles as antimicrobial agents: A review","volume":"176","author":"Ma","year":"2017","journal-title":"Carbohydr Polym"},{"issue":"20","key":"10.1016\/j.survophthal.2021.08.010_bib0110","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves' orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CE.S76549","article-title":"Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy","volume":"11","author":"Margaritopoulos","year":"2016","journal-title":"Core Evid"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0112","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40618-018-0943-8","article-title":"Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy","volume":"42","author":"Marino","year":"2019","journal-title":"J Endocrinol Investig"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2021.08.010_bib0113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000512255","article-title":"Microbiome and Graves' orbitopathy","volume":"9","author":"Masetti","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0114","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"McLachlan","year":"2014","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/thy.2012.0374","article-title":"Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa","volume":"23","author":"McLachlan","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0116","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/TCRM.S81141","article-title":"Role of pirfenidone in the management of pulmonary fibrosis","volume":"13","author":"Meyer","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0117","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41433-018-0302-1","article-title":"Clinical pathophysiology of thyroid eye disease: The Cone Model","volume":"33","author":"Meyer","year":"2019","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0118","article-title":"Rituximab for thyroid-associated ophthalmopathy","author":"Minakaran","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0119","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.18632\/oncotarget.23225","article-title":"Hypoxia-inducible factor-1alpha activates transforming growth factor-beta1\/Smad signaling and increases collagen deposition in dermal fibroblasts","volume":"9","author":"Mingyuan","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0120","doi-asserted-by":"crossref","first-page":"T29","DOI":"10.1530\/JME-17-0276","article-title":"IGF1 receptor and thyroid-associated ophthalmopathy","volume":"61","author":"Mohyi","year":"2018","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0121","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1089\/thy.2016.0323","article-title":"Thyrotropin and insulin-like growth factor 1 receptor crosstalk upregulates sodium-iodide symporter expression in primary cultures of human thyrocytes","volume":"26","author":"Morgan","year":"2016","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0122","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0035-1559633","article-title":"Graves' disease mechanisms: The role of stimulating, blocking, and cleavage region TSH receptor antibodies","volume":"47","author":"Morshed","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0123","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.07.009","article-title":"How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis","volume":"47","author":"Morshed","year":"2013","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0124","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/labinvest.2017.92","article-title":"Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses","volume":"97","author":"Muku","year":"2017","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/jpet.112.193482","article-title":"Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure","volume":"342","author":"Narayanan","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.toxlet.2013.08.013","article-title":"Comparisons of differential gene expression elicited by TCDD, PCB126, betaNF, or ICZ in mouse hepatoma Hepa1c1c7 cells and C57BL\/6 mouse liver","volume":"223","author":"Nault","year":"2013","journal-title":"Toxicol Lett"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178232","article-title":"Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice","volume":"12","author":"Nishikai-Yan Shen","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0128","doi-asserted-by":"crossref","first-page":"e98711","DOI":"10.1371\/journal.pone.0098711","article-title":"Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines","volume":"9","author":"Novotna","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20072108","article-title":"Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder","volume":"205","author":"O'Connell","year":"2008","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/01658107.2015.1039140","article-title":"Rituximab in the treatment of thyroid eye disease: A review","volume":"39","author":"Ostrowski","year":"2015","journal-title":"Neuroophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0131","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.eye.6701768","article-title":"The effect of etanercept on Graves' ophthalmopathy: a pilot study","volume":"19","author":"Paridaens","year":"2005","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0132","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ajo.2019.07.021","article-title":"A new era in the treatment of thyroid eye disease","volume":"208","author":"Patel","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2021.08.010_bib0133","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00251-013-0702-0","article-title":"PPARg2 Ala(1)(2) variant protects against Graves' orbitopathy and modulates the course of the disease","volume":"65","author":"Pawlak-Adamska","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0134","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/412158","article-title":"Markers of inflammation and fibrosis in the orbital fat\/connective tissue of patients with Graves' orbitopathy: clinical implications","volume":"2014","author":"Pawlowski","year":"2014","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0135","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/340934","article-title":"Disturbances of modulating molecules (FOXP3, CTLA-4\/CD28\/B7, and CD40\/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathy","volume":"2015","author":"Pawlowski","year":"2015","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0136","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2018.07.038","article-title":"Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy: a randomized clinical trial","volume":"195","author":"Perez-Moreiras","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0137","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20150497","article-title":"Repurposing metformin: an old drug with new tricks in its binding pockets","volume":"471","author":"Pryor","year":"2015","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0138","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bcp.2008.08.031","article-title":"The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways","volume":"77","author":"Puga","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0139","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/17469899.2014.917960","article-title":"Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside","volume":"9","author":"Rajaii","year":"2014","journal-title":"Expert Rev Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/a-0725-9297","article-title":"Reflections on thyroid autoimmunity: a personal overview from the past into the future","volume":"50","author":"Rapoport","year":"2018","journal-title":"Horm Metab Res"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0141","doi-asserted-by":"crossref","first-page":"e15296","DOI":"10.1371\/journal.pone.0015296","article-title":"PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy","volume":"5","author":"Raychaudhuri","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0142","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2010.04.004","article-title":"Do subtypes of graves' orbitopathy exist?","volume":"118","author":"Regensburg","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0143","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2010.0218","article-title":"Effect of smoking on orbital fat and muscle volume in Graves' orbitopathy","volume":"21","author":"Regensburg","year":"2011","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.survophthal.2021.08.010_bib0144","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.phrs.2009.10.005","article-title":"Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice","volume":"61","author":"Rogerio","year":"2010","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.survophthal.2021.08.010_bib0145","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00249-009-0453-x","article-title":"Structural basis of the anti-inflammatory activity of quercetin: inhibition of the 5-hydroxytryptamine type 2 receptor","volume":"38","author":"Rotelli","year":"2009","journal-title":"Eur Biophys J"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0146","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0147","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-016-1226-9","article-title":"Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves' orbitopathy","volume":"58","author":"Rotondo Dottore","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0148","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1038\/s41598-020-65414-1","article-title":"The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts","volume":"10","author":"Roztocil","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0149","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/01658107.2019.1566382","article-title":"Vitamin D and selenium in a thyroid eye disease population in Texas","volume":"43","author":"Sadaka","year":"2019","journal-title":"Neuroophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2021.08.010_bib0151","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092816","article-title":"Anti-IL-6 receptor tocilizumab in refractory Graves' orbitopathy: National Multicenter Observational Study of 48 patients","volume":"9","author":"Sanchez-Bilbao","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0152","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2147\/JIR.S228361","article-title":"Modulation of chronic inflammation by quercetin: the beneficial effects on obesity","volume":"13","author":"Sato","year":"2020","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0153","first-page":"57","article-title":"The relationship between Graves' ophthalmopathy and dry eye syndrome","volume":"9","author":"Selter","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2021.08.010_bib0154","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1530\/EC-19-0319","article-title":"Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves' ophthalmopathy patients","volume":"8","author":"Shahida","year":"2019","journal-title":"Endocr Connect"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/phar.2111","article-title":"Efficacy and safety of rituximab for the treatment of Graves' orbitopathy: A meta-analysis of randomized controlled trials","volume":"38","author":"Shen","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2021.08.010_bib0156","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.7861\/clinmed.20-2-s57","article-title":"Tocilizumab-induced pulmonary fibrosis in a patient with rheumatoid arthritis","volume":"20","author":"Silva","year":"2020","journal-title":"Clin Med (Lond)"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0157","doi-asserted-by":"crossref","DOI":"10.3390\/md18120627","article-title":"Recent advances in marine-based nutraceuticals and their health benefits","volume":"18","author":"\u0160imat","year":"2020","journal-title":"Mar Drugs"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0158","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archopht.119.6.868","article-title":"The color difference in orbital fat","volume":"119","author":"Sires","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"16","key":"10.1016\/j.survophthal.2021.08.010_bib0159","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocr Rev"},{"issue":"18","key":"10.1016\/j.survophthal.2021.08.010_bib0161","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0162","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0163","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1096\/fj.201500129","article-title":"TGF-beta-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8","volume":"30","author":"Spanjer","year":"2016","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0164","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-16-0552","article-title":"Management of endocrine disease: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials","volume":"176","author":"Stan","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/jc.2002-020987","article-title":"Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?","volume":"88","author":"Starkey","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0166","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","article-title":"Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease","volume":"133","author":"Stein","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"4S Suppl 1","key":"10.1016\/j.survophthal.2021.08.010_bib0167","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/IOP.0000000000001131","article-title":"Efficacy and safety of immunosuppressive agents for thyroid eye disease","volume":"34","author":"Strianese","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0168","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41433-018-0315-9","article-title":"Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy","volume":"33","author":"Strianese","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109604","article-title":"Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects","volume":"121","author":"Tang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"10.1016\/j.survophthal.2021.08.010_bib0170","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1167\/iovs.17-22237","article-title":"RNA-sequencing gene expression profiling of orbital adipose-derived stem cell population implicate HOX genes and WNT signaling dysregulation in the pathogenesis of thyroid-associated orbitopathy","volume":"58","author":"Tao","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0171","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0172","first-page":"324","article-title":"MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy","volume":"21","author":"Tong","year":"2015","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0173","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0174","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/iovs.61.8.17","article-title":"Retinoic acid potentiates orbital tissues for inflammation through NF-kappaB and MCP-1","volume":"61","author":"Unsworth","year":"2020","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1272\/jnms.79.46","article-title":"Sequential analysis of myofibroblast differentiation and transforming growth factor-\u03b21\/Smad pathway activation in murine pulmonary fibrosis","volume":"79","author":"Usuki","year":"2012","journal-title":"J Nippon Med Sch"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0176","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/jc.2012-2270","article-title":"Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathy","volume":"98","author":"Varewijck","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0177","first-page":"501","article-title":"Oxidative stress in lens in vivo: inhibitory effect of caffeine. A preliminary report","volume":"16","author":"Varma","year":"2010","journal-title":"Mol Vis"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0178","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/10715760802626535","article-title":"Inhibition of reactive oxygen species and pre-neoplastic lesions by quercetin through an antioxidant defense mechanism","volume":"43","author":"V\u00e1squez-Garz\u00f3n","year":"2009","journal-title":"Free Radic Res"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0179","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12886-018-0679-4","article-title":"Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0180","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/toxsci\/kfv246","article-title":"Ah receptor activation by dioxin disrupts activin, BMP, and WNT signals during the early differentiation of mouse embryonic stem cells and inhibits cardiomyocyte functions","volume":"149","author":"Wang","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0181","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/TCRM.S193018","article-title":"Thyroid eye disease: how a novel therapy may change the treatment paradigm","volume":"15","author":"Wang","year":"2019","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0182","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40123-020-00318-x","article-title":"Physician-perceived impact of thyroid eye disease on patient quality of life in the United States","volume":"10","author":"Wang","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0183","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fcell.2020.00818","article-title":"MicroRNAs and autoimmune-mediated eye diseases","volume":"8","author":"Wei","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0184","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/wdev.86","article-title":"The TGFbeta superfamily signaling pathway","volume":"2","author":"Weiss","year":"2013","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0185","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of Graves' ophthalmopathy","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0186","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000348246","article-title":"Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathy","volume":"2","author":"Wiersinga","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0187","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgz183","article-title":"miR-155 as a novel clinical target for hematological malignancies","volume":"41","author":"Witten","year":"2020","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0188","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1096\/fj.14-257121","article-title":"Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn","volume":"29","author":"Woeller","year":"2015","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.survophthal.2021.08.010_bib0189","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1074\/jbc.M114.601872","article-title":"Salinomycin and other polyether ionophores are a new class of antiscarring agent","volume":"290","author":"Woeller","year":"2015","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.survophthal.2021.08.010_bib0190","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1167\/iovs.19-27865","article-title":"TSHR signaling stimulates proliferation through PI3K\/Akt and induction of miR-146a and miR-155 in thyroid eye disease orbital fibroblasts","volume":"60","author":"Woeller","year":"2019","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.survophthal.2021.08.010_bib0191","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.ajpath.2016.08.017","article-title":"The aryl hydrocarbon receptor and its ligands inhibit myofibroblast formation and activation: implications for thyroid eye disease","volume":"186","author":"Woeller","year":"2016","journal-title":"Am J Pathol"},{"issue":"8 Suppl 1","key":"10.1016\/j.survophthal.2021.08.010_bib0192","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/JOM.0000000000000742","article-title":"Detection of serum microRNAs from department of defense serum repository: correlation with cotinine, cytokine, and polycyclic aromatic hydrocarbon levels","volume":"58","author":"Woeller","year":"2016","journal-title":"J Occup Environ Med"},{"issue":"7","key":"10.1016\/j.survophthal.2021.08.010_bib0193","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1167\/iovs.10-7066","article-title":"Ocular fibroblast diversity: implications for inflammation and ocular wound healing","volume":"52","author":"Xi","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0194","first-page":"509","article-title":"Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy","volume":"24","author":"Xiong","year":"2018","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0195","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biopha.2017.03.105","article-title":"MiR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis","volume":"90","author":"Xu","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.survophthal.2021.08.010_bib0196","doi-asserted-by":"crossref","first-page":"e97419","DOI":"10.1371\/journal.pone.0097419","article-title":"Nrf2-inducing anti-oxidation stress response in the rat liver\u2013new beneficial effect of lansoprazole","volume":"9","author":"Yamashita","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.survophthal.2021.08.010_bib0197","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1038\/s41598-019-46075-1","article-title":"Macrophages promote a profibrotic phenotype in orbital fibroblasts through increased hyaluronic acid production and cell contractility","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2021.08.010_bib0198","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2013.04.003","article-title":"The long and short of microRNA","volume":"153","author":"Yates","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0199","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8060182","article-title":"miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4 axis in atherogenesis","volume":"2016","author":"Ye","year":"2016","journal-title":"Mediat Inflamm"},{"issue":"11","key":"10.1016\/j.survophthal.2021.08.010_bib0200","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1089\/thy.2008.0098","article-title":"Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy","volume":"18","author":"Yin","year":"2008","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.survophthal.2021.08.010_bib0201","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s11033-008-9386-1","article-title":"Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways","volume":"36","author":"Ying","year":"2009","journal-title":"Mol Biol Rep"},{"issue":"9","key":"10.1016\/j.survophthal.2021.08.010_bib0202","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1167\/iovs.12-9646","article-title":"Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy","volume":"53","author":"Yoon","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2021.08.010_bib0203","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/bjophthalmol-2012-301537","article-title":"Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy","volume":"96","author":"Yoon","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.08.010_bib0204","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JOE-12-0257","article-title":"Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress","volume":"216","author":"Yoon","year":"2013","journal-title":"J Endocrinol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.08.010_bib0205","doi-asserted-by":"crossref","first-page":"e26261","DOI":"10.1371\/journal.pone.0026261","article-title":"Quercetin inhibits IL-1\u03b2-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy","volume":"6","author":"Yoon","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0206","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/302537","article-title":"The role of oxidative stress on the pathogenesis of graves' disease","volume":"2012","author":"Zarkovi\u0107","year":"2012","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.survophthal.2021.08.010_bib0207","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3389\/fphar.2018.01181","article-title":"Curcumin's metabolites, tetrahydrocurcumin and octahydrocurcumin, possess superior anti-inflammatory effects in vivo through suppression of TAK1-NF-\u03baB pathway","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:53:24Z","timestamp":1758542004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625721001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":207,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0039625721001831"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.08.010","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}